Articles
Perfetto EM, Burke L, Love TR, Schrandt MS & Hobart J (2023) 'Measuring Health and Well-Being: We Need to Get it Right for Patients, With Patients' Value in Health 26, (3) 435-437 ,
DOI
Hobart J, Butzkueven H, Haartsen J, Ziemssen T, Lane T & Giovannoni G (2022) 'Timely intervention, monitoring and education MATTERS in MS (TIME MATTERS in MS): Development of a globally applicable quality improvement tool' Multiple Sclerosis Journal - Experimental, Translational and Clinical 8, (3) ,
DOI Open access
Bharadia T, Vandercappellen J, Chitnis T, Eelen P, Bauer B, Brichetto G, Lloyd A, Schmidt H, King M & Fitzgerald J (2022) 'Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables?' Multiple Sclerosis Journal - Experimental, Translational and Clinical 8, (2) 205521732211056-205521732211056 ,
DOI Open access
Dobson R, Craner M, Waddingham E, Miller A, Pindoria J, Cavey A, Blain C, De Luca G, Evangelou N & Ford H (2022) 'Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)' Multiple Sclerosis and Related Disorders 63, ,
DOI Open access
Hupperts R, Gasperini C, Lycke J, Ziemssen T, Feys P, McNeill M, Acosta C, Koster T & Hobart J (2022) 'Efficacy of prolonged-release fampridine versus placebo on walking ability, dynamic and static balance, physical impact of multiple sclerosis, and quality of life: an integrated analysis of MOBILE and ENHANCE' Therapeutic Advances in Neurological Disorders ,
DOI Open access
Zaratin P, Vermersch P, Amato MP, Brichetto G, Coetzee T, Cutter G, Edan G, Giovannoni G, Gray E & Hartung HP (2022) 'The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questions' Multiple Sclerosis and Related Disorders 61, 103757-103757 ,
DOI
Satukijchai C, Mariano R, Messina S, Sa M, Woodhall MR, Robertson NP, Ming L, Wassmer E, Kneen R & Huda S (2022) 'Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease in the United Kingdom' JAMA Network Open 5, (1) ,
DOI Open access
Smets I, Holden D, Bianchi L, Ammoscato F, Allen-Philbey K, Baker D, Turner B, Marta M, Giovannoni G & Macdougall A (2022) 'Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study' Multiple Sclerosis and Related Disorders 57, 103409-103409 ,
DOI
Hupperts R, Gasperini C, Lycke J, Ziemssen T, Feys P, Xiao S, Acosta C, Koster T & Hobart J (2022) 'Efficacy of prolonged-release fampridine <i>versus</i> placebo on walking ability, dynamic and static balance, physical impact of multiple sclerosis, and quality of life: an integrated analysis of MOBILE and ENHANCE' Therapeutic Advances in Neurological Disorders 15, ,
DOI Open access
Dobson R, Craner M, Waddingham E, Miller A, Cavey A, Webb S, Hemingway C, Hobart J, Evangelou N & Scolding N (2021) 'OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis' BMJ Open 11, (11) ,
DOI Open access
Rodgers J, Friede T, Vonberg FW, Constantinescu CS, Coles A, Chataway J, Duddy M, Emsley H, Ford H & Fisniku L (2021) 'The impact of smoking cessation on multiple sclerosis disease progression' Brain ,
DOI Open access
Hobart J (2021) 'Hyperhidrosis Disease Severity Measure-Axillary (HDSM-Ax): Evaluation of Measurement Performance' Journal of drugs in dermatology : JDD ,
DOI Open access
Allen-Philbey K, De Trane S, Mao Z, Álvarez-González C, Mathews J, MacDougall A, Stennett A, Zhou X, Yildiz O & Adams A (2021) 'Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients' Therapeutic Advances in Neurological Disorders 14, ,
DOI Open access
Ziemssen T, Bass A, Berkovich R, Comi G, Eichau S, Hobart J, Hunter SF, LaGanke C, Limmroth V & Pelletier D (2020) 'Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study' CNS Drugs ,
DOI Open access
Sá MJ, Soares dos Reis R, Altintas A, Celius EG, Chien C, Comi G, Graus F, Hillert J, Hobart J & Khan G (2020) 'State of the Art and Future Challenges in Multiple Sclerosis Research and Medical Management: An Insight into the 5th International Porto Congress of Multiple Sclerosis' Neurology and Therapy ,
DOI Open access
Hobart J & Giovannoni G (2020) 'Cognition and its relation to brain health in patients with MS: Response to letter' Multiple Sclerosis Journal 26, (12) 1613-1614 ,
DOI Open access
Lin S, Green H, Hendy P, Heerasing N, Chanchlani N, Hamilton B, Walker G, Heap G, Hobart J & Martin R (2020) 'Clinical features and genetic risk of demyelination following anti-TNF treatment' Journal of Crohn's and Colitis ,
DOI Open access
Close J, Baines K, Burke L & Hobart J (2020) 'Measuring upper limb function in MS: Which existing patient reported outcomes are fit for purpose?' eNeurologicalSci 19, 100237-100237 ,
DOI Open access
Chataway J, De Angelis F, Connick P, Parker RA, Plantone D, Doshi A, John N, Stutters J, MacManus D & Prados Carrasco F (2020) 'Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial' The Lancet Neurology 19, (3) 214-225 ,
DOI Open access
Hobart JC, Ziemssen T, Feys P, Linnebank M, Goodman AD, Farrell R, Hupperts R, Blight AR, Englishby V & McNeill M (2018) 'Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-blind, Phase III ENHANCE Trial of Prolonged-release Fampridine' CNS Drugs 33, (1) 61-79 ,
DOI Open access
Germon T, Clifford D, Lee W & Hobart J (2018) 'Low back pain' The Lancet 392, (10164) 2547-2547 ,
DOI Open access
Hobart JC (2018) 'International consensus on quality standards for brain health-focused care in multiple sclerosis' Multiple Sclerosis Journal ,
DOI Open access
Hobart J, Bowen A, Pepper G, Crofts H, Eberhard L, Berger T, Boyko A, Boz C, Butzkueven H & Celius EG (2018) 'International consensus on quality standards for brain health-focused care in multiple sclerosis' Multiple Sclerosis 1352458518809326-1352458518809326 Author Site ,
DOI Open access
Albrecht P, Bjorna IK, Brassat D, Farrell R, Feys P, Hobart JC, Hupperts R, Linnebank M, Magdic J & Oreja-Guevara C (2018) 'Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience – report of an expert meeting' Therapeutic Advances in Neurological Disorders ,
DOI Open access
Kirsch BM, Burke L, Hobart J, Angulo D & Walker PS (2018) 'The Hyperhidrosis Disease Severity Measure-Axillary: Conceptualization and Development of Item Content' Journal of Drugs in Dermatology Open access
Middleton RM, Rodgers WJ, Chataway J, Schmierer K, Rog D, Galea I, Akbari A, Tuite-Dalton K, Lockhart-Jones H & Griffiths D (2018) 'Validating the portal population of the United Kingdom Multiple Sclerosis Register' Multiple Sclerosis and Related Disorders 24, 3-10 ,
DOI
Kapoor R, Ho P-R, Campbell N, Chang I, Deykin A, Forrestal F, Lucas N, Yu B, Arnold DL & Freedman MS (2018) 'Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension' The Lancet Neurology 17, (5) 405-415 ,
DOI
Hobart JC, Hussein D, Yusef T & Murat T (2017) 'Testing patient-reported outcome measurement equivalence in multinational clinical trials: An exemplar using the 12-item Multiple Sclerosis Walking Scale' Multiple Sclerosis Journal - Experimental, Translational and Clinical 3, (3) ,
DOI Open access
Powers JH, Patrick DL, Walton MK, Marquis P, Cano S, Hobart J, Isaac M, Vamvakas S, Slagle A & Molsen E (2017) 'Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force' Value in Health 20, (1) 2-14 ,
DOI
Vermersch P, Hobart J, Dive-Pouletty C, Bozzi S, Hass S & Coyle PK (2016) 'Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose?' Multiple Sclerosis Journal 23, (4) 604-613 ,
DOI Open access
Giovannoni G, Butzkueven H, Dhib-Jalbut S, Hobart J, Kobelt G, Pepper G, Sormani MP, Thalheim C, Traboulsee A & Vollmer T (2016) 'Brain health: time matters in multiple sclerosis' Multiple Sclerosis and Related Disorders 9, S5-S48 ,
DOI Open access
Ofori J, Freeman J, Logan A, Rapson R, Zajieck J, Hobart J & Marsden JF (2016) 'An investigation of commonly prescribed stretches of the ankle plantarflexors in people with Multiple Sclerosis' Clinical Biomechanics 37, 22-26 ,
DOI Open access
Hobart J (2016) 'Measuring spinal surgical success: the proportion achieving acceptable symptoms' The Spine Journal 16, (4) S19-S20 ,
DOI Open access
Cano S, Cleanthous S, Marquis P, Hobart J, Naoshy S, Mikol D, Petrillo J, Steiner D & Watson C (2015) 'Measuring the Impact of Multiple Sclerosis: Enhancing the Performance of the Msis-29 and Msws-12' Value in Health 18, (7) A709-A710 ,
DOI
Cano S, Cleanthous S, Marquis P, Hobart J, Naoshy S, Mikol D, Petrillo J, Steiner D & Watson C (2015) 'Measuring the Impact of Secondary Progressive Multiple Sclerosis (Spms) in the Ascend Trial: Equating the Msis-29, Msws-12, Abilhand-56 and Sf-36' Value in Health 18, (7) A713-A713 ,
DOI
Walton MK, Powers JH, Hobart J, Patrick D, Marquis P, Vamvakas S, Isaac M, Molsen E, Cano S & Burke LB (2015) 'Clinical Outcome Assessments: Conceptual Foundation—Report of the ISPOR Clinical Outcomes Assessment – Emerging Good Practices for Outcomes Research Task Force' Value in Health 18, (6) 741-752 ,
DOI
Mehta L, McNeill M, Hobart J, Wyrwich KW, Poon J-L, Auguste P, Zhong J & Elkins J (2015) 'Identifying an important change estimate for the Multiple Sclerosis Walking Scale-12 (MSWS-12v1) for interpreting clinical trial results' Multiple Sclerosis Journal - Experimental, Translational and Clinical 1, 205521731559699-205521731559699 ,
DOI
Baker K, Barrett L, Playford ED, Aspden T, Riazi A & Hobart J (2015) 'Measuring arm function early after stroke: is the DASH good enough?' Journal of Neurology, Neurosurgery & Psychiatry 87, (6) 604-610 ,
DOI Open access
Germon T & Hobart J (2015) 'People receiving unnecessary treatments: accurate diagnosis is key' BMJ 350, (jun02 26) h2962-h2962 ,
DOI
Mehta L, McNeill M, Hobart J, Wyrwich K, Poon JL, Auguste P, Zhong J & Elkins J (2015) 'Identifying a Minimally Important Change Threshold for The Multiple Sclerosis Walking Scale-12 (MSWS-12)' MULTIPLE SCLEROSIS JOURNAL 21, (6) 813-814 Author Site Open access
Cano S, Cleanthous S, Marquis P, Hobart J, Naoshy S, Mikol D, Petrillo J, Steiner D, Chen Y & Watson C (2015) 'Measuring Upper Limb Function In Multiple Sclerosis: Enhancing The Abilhand’s Performance' Value in Health 18, (3) A24-A24 ,
DOI
Barrett L, Cano S, Zajicek J & Hobart J (2015) 'Lending a hand: can DASH items help ABILHAND improve manual ability measurement in multiple sclerosis?' Mult Scler 21, (5) 612-621 Author Site ,
DOI
Germon TJ & Hobart JC (2015) 'Definitions, diagnosis, and decompression in spinal surgery: problems and solution' Spine J 15, (3 Suppl) S5-S8 Author Site ,
DOI
Ball S, Vickery J, Hobart J, Wright D, Green C, Shearer J, Nunn A, Cano MG, MacManus D & Miller D (2015) 'The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis' Health Technol Assess 19, (12) vii-187 Author Site ,
DOI
Germon T, Singleton W & Hobart J (2014) 'Is NICE guidance for identifying lumbar nerve root compression misguided?' Eur Spine J 23 Suppl 1, (Suppl 1) S20-S24 Author Site ,
DOI
Hobart J, Cano S, Baron R, Thompson A, Schwid S, Zajicek J & Andrich D (2013) 'Achieving valid patient-reported outcomes measurement: a lesson from fatigue in multiple sclerosis' Mult Scler 19, (13) 1773-1783 Author Site ,
DOI Open access
Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, Cotsapas C, Shah TS, Spencer C, Booth D & Goris A (2013) 'Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis' NATURE GENETICS 45, (11) 1353-+ Author Site ,
DOI
Zajicek J, Ball S, Wright D, Vickery J, Nunn A, Miller D, Gomez Cano M, McManus D, Mallik S & Hobart J (2013) 'Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial' Lancet Neurology 2013, 1-9 ,
DOI
Mechelli R, Umeton R, Policano C, Annibali V, Coarelli G, Ricigliano VAG, Vittori D, Fornasiero A, Buscarinu MC & Romano S (2013) 'A “Candidate-Interactome” Aggregate Analysis of Genome-Wide Association Data in Multiple Sclerosis' PLoS ONE 8, (5) e63300-e63300 ,
DOI Open access
Barrett LE, Cano SJ, Zajicek JP & Hobart JC (2013) 'Can the ABILHAND handle manual ability in MS?' Mult Scler 19, (6) 806-815 Author Site ,
DOI
Hobart J, Blight AR, Goodman A, Lynn F & Putzki N (2013) 'Timed 25-foot walk: direct evidence that improving 20% or greater is clinically meaningful in MS' Neurology 80, (16) 1509-1517 Author Site ,
DOI
Freeman J, Walters R, Ingram W, Slade A, Hobart J & Zajicek J (2013) 'Evaluating change in mobility in people with multiple sclerosis: relative responsiveness of four clinical measures' Multiple Sclerosis Journal 1-8 ,
DOI
Freeman J, Walters R, Ingram W, Slade A, Hobart J & Zajicek J (2013) 'Evaluating change in mobility in people with multiple sclerosis: relative responsiveness of four clinical measures' Mult Scler 19, (12) 1632-1639 Author Site ,
DOI
Hobart J, Gilkes C, Adams W & Germon T (2013) 'Interspinous spacers for lumbar foraminal stenosis: formal trials are justified' Eur Spine J 22 Suppl 1, (Suppl 1) S47-S53 Author Site ,
DOI
Hobart J, Cano S, Posner H, Selnes O, Stern Y, Thomas R, Zajicek J & Alzheimer's Disease Neuroimaging Initiative (2013) 'Putting the Alzheimer's cognitive test to the test I: traditional psychometric methods' Alzheimers Dement 9, (1 Suppl) S4-S9 Author Site ,
DOI
Hobart J, Cano S, Posner H, Selnes O, Stern Y, Thomas R, Zajicek J & Alzheimer's Disease Neuroimaging Initiative (2013) 'Putting the Alzheimer's cognitive test to the test II: Rasch Measurement Theory' Alzheimers Dement 9, (1 Suppl) S10-S20 Author Site ,
DOI
Posner HB, Cano S, Carrillo MC, Selnes O, Stern Y, Thomas RG, Zajicek J & Hobart J (2013) 'Establishing the psychometric underpinning of cognition measures for clinical trials of Alzheimer's disease and its precursors: A new approach' Alzheimer's & Dementia 9, (1S) ,
DOI
Hobart JC, Cano SJ, Warner TT & Thompson AJ (2012) 'What sample sizes for reliability and validity studies in neurology?' J Neurol 259, (12) 2681-2694 Author Site ,
DOI
Zajicek JP, Hobart JC, Slade A, Barnes D, Mattison PG & MUSEC Research Group (2012) 'Multiple sclerosis and extract of cannabis: results of the MUSEC trial' J Neurol Neurosurg Psychiatry 83, (11) 1125-1132 Author Site ,
DOI
Zajicek JP, Hobart JC, Slade A, Barnes D, Rickards C & Mattison P (2012) 'Multiple Sclerosis and Extract of Cannabis (MUSEC) – a randomised, double-blind, placebo-controlled phase III trial to determine the efficacy and safety of a standardised oral extract of Cannabis sativa for the symptomatic relief of muscle stiffness and pain in multiple sclerosis' Journal of Neurology, Neurosurgery and Psychiatry 83, 1125-1132 Publisher Site ,
DOI
Bladh S, Nilsson MH, Hariz G-M, Westergren A, Hobart J & Hagell P (2012) 'Psychometric performance of a generic walking scale (Walk-12G) in multiple sclerosis and Parkinson's disease' JOURNAL OF NEUROLOGY 259, (4) 729-738 Author Site ,
DOI
Apostu V, Zajicek J & Hobart J (2012) '125 Campath-1H for multiple sclerosis: a pain in the neck?' Journal of Neurology, Neurosurgery & Psychiatry 83, (3) e1.76-e1 ,
DOI
Hobart J (2011) 'Multiple Sclerosis Walking Scale (MSWS-12): changes on all items are not equal' MULTIPLE SCLEROSIS JOURNAL 17, S92-S93 Author Site
Hobart J (2011) 'Multiple Sclerosis Walking Scale (MSWS-12): exactly what clinical benefits do prolonged-release fampridine responders actually get?' MULTIPLE SCLEROSIS JOURNAL 17, S319-S320 Author Site
McGuigan C, Schapiro R, Putzki N & Hobart J (2011) 'Responses to items of the MSWS-12 differ depending on EDSS and the impact of prolonged-release fampridine on walking speed' MULTIPLE SCLEROSIS JOURNAL 17, S473-S474 Author Site
Riazi A, Porter B, Chataway J, Thompson AJ & Hobart JC (2011) 'A tool to measure the attributes of receiving IV therapy in a home versus hospital setting: the Multiple Sclerosis Relapse Management Scale (MSRMS)' Health Qual Life Outcomes 9, Author Site ,
DOI Open access
(2011) 'Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis' Nature 476, (7359) 214-219 ,
DOI Open access
Cano S, Barrett L, Zajicek J & Hobart J (2011) 'Dimensionality is a relative concept' Mult Scler 17, (7) 893-894 ,
DOI
Cano SJ, Barrett LE, Zajicek JP & Hobart JC (2011) 'Beyond the reach of traditional analyses: using Rasch to evaluate the DASH in people with multiple sclerosis' Mult Scler 17, (2) 214-222 Author Site ,
DOI
Cano SJ & Hobart JC (2011) 'The problem with health measurement' Patient Prefer Adherence 5, 279-290 Author Site ,
DOI Open access
Cano SJ, Posner HB, Moline ML, Hurt SW, Swartz J, Hsu T & Hobart JC (2010) 'The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts' J Neurol Neurosurg Psychiatry 81, (12) 1363-1368 Author Site ,
DOI
Zajicek JP, Ingram WM, Vickery J, Creanor S, Wright DE & Hobart JC (2010) 'Patient-orientated longitudinal study of multiple sclerosis in south west England (The South West Impact of Multiple Sclerosis Project, SWIMS) 1: protocol and baseline characteristics of cohort' BMC Neurol 10, Author Site ,
DOI Open access
Freeman RG, Cano S, Slade A, Delatycki M, Tai G & Hobart J (2010) 'Cross-cultural Comparisons: Lessons from Friedreich's Ataxia' QUALITY OF LIFE RESEARCH 19, 64-65 Author Site
Slade AL, Zajicek JP, Ingram WM, Freeman RG, Cano S & Hobart JC (2010) 'Does a Rasch-modified FSS deliver better measurements?' QUALITY OF LIFE RESEARCH 19, 89-89 Author Site
Hobart JC & Cano SJ (2010) 'Effect sizes can be misleading: Is it time to change the way we measure change?' QUALITY OF LIFE RESEARCH 19, 41-41 Author Site
Cano SJ & Hobart JC (2010) 'Validity in fatigue measurement: complementing quality and quantity' QUALITY OF LIFE RESEARCH 19, 14-14 Author Site
Hobart JC, Cano SJ & Thompson AJ (2010) 'Effect sizes can be misleading: is it time to change the way we measure change?' J Neurol Neurosurg Psychiatry 81, (9) 1044-1048 Author Site ,
DOI
Hobart J (2010) 'F5‐01‐02: ADAS‐cog reanalyses' Alzheimer's & Dementia 6, (4S_Part_6) ,
DOI
Littleton ET, Hobart JC & Palace J (2010) 'Modafinil for multiple sclerosis fatigue: Does it work?' CLINICAL NEUROLOGY AND NEUROSURGERY 112, (1) 29-31 Author Site ,
DOI
Osmani D, Rajagopalan K & Hobart J (2009) 'LINGUISTIC VALIDATION OF THE MULTIPLE SCLEROSIS IMPACT SCALE (MSIS-29) FOR USE IN 29 LANGUAGES' VALUE IN HEALTH 12, (7) A371-A371 Author Site ,
DOI
Cano S, Posner H, Aisen P, Selnes O, Stern Y, Thomas R, Weiner M, Zajicek J, Zeger S & Hobart J (2009) 'O4‐04‐07: The ADAS‐cog's performance as a measure—lessons from the ADNI study: Part 2 ‐ evaluation using modern psychometric methods' Alzheimer's & Dementia 5, (4S_Part_5) ,
DOI
Posner H, Cano S, Aisen P, Selnes O, Stern Y, Thomas R, Weiner M, Zajicek J, Zeger S & Hobart J (2009) 'P1‐269: The ADAS‐cog's performance as a measure ‐ lessons from the ADNI study: Part 1 ‐ evaluation using traditional psychometric methods' Alzheimer's & Dementia 5, (4S_Part_9) ,
DOI
Hobart J, Posner H, Aisen P, Selnes O, Stern Y, Thomas R, Weiner M, Zajicek J, Zeger S & Cano S (2009) 'P1‐270: The ADAS‐cog's performance as a measure ‐ lessons from the ADNI study: Part 3 ‐ do the scale modifications add value?' Alzheimer's & Dementia 5, (4S_Part_9) ,
DOI
Cano SJ, Riazi A, Schapira AHV, Cooper JM & Hobart JC (2009) 'Friedreich's ataxia impact scale: a new measure striving to provide the flexibility required by today's studies' Mov Disord 24, (7) 984-992 Author Site ,
DOI
van der Linden FAH, Kragt JJ, Hobart JC, Klein M, Thompson AJ, van der Ploeg HM, Polman CH & Uitdehaag BMJ (2009) 'The size of the treatment effect: do patients and proxies agree?' BMC NEUROLOGY 9, Author Site ,
DOI Open access
Posner H, Cano S, Aisen P, Selnes O, Stern Y, Thomas R, Weiner M, Zajicek J, Zeger S & Hobart J (2009) 'The ADAS-cog's Performance as a Measure- Lessons from the ADNI study. Part 1 Evaluation using traditional Psychometric Methods AAN' Neurology (72)
Hobart J & Cano S (2009) 'Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods' Health Technol Assess 13, (12) iii-177 Author Site ,
DOI
Cano SJ, Warner TT, Thompson AJ, Bhatia KP, Fitzpatrick R & Hobart JC (2008) 'The cervical dystonia impact profile (CDIP-58): can a Rasch developed patient reported outcome measure satisfy traditional psychometric criteria?' Health Qual Life Outcomes 6, Author Site ,
DOI Open access
Cano SJ & Hobart JC (2008) 'Watch out, watch out, the FDA are about' Dev Med Child Neurol 50, (6) 408-409 Author Site ,
DOI
Cano S & Hobart J (2008) 'Taking a lead against evil - Response' PSYCHOLOGIST 21, (2) 169-169 Author Site
Hagell P, Tornqvist AL & Hobart J (2008) 'Testing the SF-36 in Parkinson's disease' JOURNAL OF NEUROLOGY 255, (2) 246-254 Author Site ,
DOI
Cano S & Hobart J (2008) 'Item response' Psychologist 21, (2)
Hobart JC & Cano SJ (2008) 'Rating scales for clinical studies in neurology: challenges and opportunities' US Neurology 4, (1)
Schrag A, Selai C, Mathias C, Low P, Hobart J, Brady N & Quinn NP (2007) 'Measuring health-related quality of life in MSA: the MSA-QoL' Mov Disord 22, (16) 2332-2338 Author Site ,
DOI
Hobart JC, Cano SJ, Zajicek JP & Thompson AJ (2007) 'Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations' Lancet Neurol 6, (12) 1094-1105 Author Site ,
DOI
Campbell J, Winder R, Richards SH & Hobart J (2007) 'Exploring the relationships between provision of welfare benefits advice and the health of elderly people: a longitudinal observational study and discussion of methodological issues' Health Soc Care Community 15, (5) 454-463 Author Site ,
DOI
Katzenschlager R, Schrag A, Evans A, Manson A, Carroll CB, Ottaviani D, Lees AJ & Hobart J (2007) 'Quantifying the impact of dyskinesias in PD: the PDYS-26: a patient-based outcome measure' Neurology 69, (6) 555-563 Author Site ,
DOI
Hobart J (2007) 'Measuring outcomes in clinical trials of stroke: time for state-of-the-art clinical trials to reject state-of-the-ark rating scales' JOURNAL OF NEUROLOGY 254, (8) 1119-1119 Author Site ,
DOI
Cano SJ, Zajicek JP, Thompson AJ & Hobart JC (2007) 'Beware all neurologists: The FDA's tough new requirements for rating scale performance are coming to a study near you soon' Journal of Neurology Neurosurgery and Psychiatry 78, (9)
Cano SJ, Thompson AJ, Bhatia K, Fitzpatrick R, Warner TT & Hobart JC (2007) 'Evidence-based guidelines for using the short form 36 in cervical dystonia' Movement Disorders 22, (1) 122-126
Campbell J, Winder R, Richards SH & Hobart J (2007) 'Exploring the relationships between provision of welfare benefits advice and the health of elderly people: a longitudinal observational study and discussion of methodological issues' Health & Social Care in the Community 15, (5) 454-463
Schrag A, Selai C, Mathias C, Low P, Hobart J, Brady N & Quinn NP (2007) 'Measuring health-related quality of life in MSA: The MSA-QoL' Movement Disorders 22, (16) 2332-2338
Hobart JH (2007) 'Measuring with rating scales - principles of measurements' Multiple Sclerosis 13, S15-S15
van Ter Linden FAH, Kragt JJ, Hobart JH, Klein M, Thompson AJ, van der Ploeg HM, Polman CH & Uitdehaag BMJ (2007) 'Proxy measurements in MS: does patient's cognitive impairment influence patient-proxy agreement on disease impact?' Multiple Sclerosis 13, S213-S213
Katzenschlager R, Schrag A, Evans A, Manson A, Carroll CB, Ottaviani D, Lees AJ & Hobart J (2007) 'Quantifying the impact of dyskinesias in PD - The PDYS-26: A patient-based outcome measure' Neurology 69, (6) 555-563
Cano SJ, Thompson AJ, Bhatia K, Fitzpatrick R, Warner TT & Hobart JC (2007) 'Evidence-based guidelines for using the Short Form 36 in cervical dystonia' Mov Disord 22, (1) 122-126 Author Site ,
DOI
Hobart JC, Thompson AJ, Zajicek JP & Cano SJ (2007) 'Rating scale responsiveness: Its time to change the way we measure change' Journal of Neurology Neurosurgery and Psychiatry 78, (9)
Hobart JC, Cano SJ, Zajicek JP & Thompson AJ (2007) 'Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations' Lancet Neurology 6, (12) 1094-1105
Hobart JC & Cano SJ (2007) 'Sample size calculations for evaluating neurological rating scales: How many is enough?' Journal of Neurology Neurosurgery and Psychiatry 78, (9)
Cano SJ & Hobart JC (2007) 'Selecting the right rating scale: Do neurologists have to have what they're given or can they get what they need?' Journal of Neurology Neurosurgery and Psychiatry 78, (9)
Cano SJ, Hobart JC, Edwards M, Fitzpatrick R, Bhatia K, Thompson AJ & Warner TT (2006) 'CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia' Neurology 67, (12) 2230-2232 Author Site ,
DOI
Cano SJ, O'Connor RJ, Thompson AJ & Hobart JC (2006) 'Exploring disability rating scale responsiveness II: do more response options help?' Neurology 67, (11) 2056-2059 Author Site ,
DOI
Holland A, O'Connor RJ, Thompson AJ, Playford ED & Hobart JC (2006) 'Talking the talk on walking the walk: a 12-item generic walking scale suitable for neurological conditions?' J Neurol 253, (12) 1594-1602 Author Site ,
DOI
Baron R, Elashaal A, Germon T & Hobart J (2006) 'Measuring outcomes in cervical spine surgery: think twice before using the SF-36' Spine (Phila Pa 1976) 31, (22) 2575-2584 Author Site ,
DOI
van der Linden FAH, Kragt JJ, Hobart JC, Klein M, Thompson AJ, van der Ploeg HM, Polman CH & Uitdehaag BMJ (2006) 'Proxy measurements in multiple sclerosis: agreement between patients and their partners on the impact of multiple sclerosis in daily life' JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY 77, (10) 1157-1162 Author Site ,
DOI
Riazi A, Cano SJ, Cooper JM, Bradley JL, Schapira AHV & Hobart JC (2006) 'Coordinating outcomes measurement in ataxia research: do some widely used generic rating scales tick the boxes?' Mov Disord 21, (9) 1396-1403 Author Site ,
DOI
Chataway J, Porter B, Riazi A, Heaney D, Watt H, Hobart J & Thompson A (2006) 'Home versus outpatient administration of intravenous steroids for multiple-sclerosis relapses: a randomized controlled trial' American Journal of Ophthalmology 142, (3) 535-535 ,
DOI
Schrag A, Selai C, Quinn N, Lees A, Litvan I, Lang A, Poon Y, Bower J, Burn D & Hobart J (2006) 'Measuring quality of life in PSP: the PSP-QoL' Neurology 67, (1) 39-44 Author Site ,
DOI
Chataway JC, Porter D, Heaney D, Riazi, Watt H, Hobart JC & Thompson AJ (2006) 'Treating multiple sclerosis relapses at home or in hospital out-patients: a randomised controlled trial of intravenous steroid delivery' Lancet Neurology 7, (5) 565-571
Hobart, Chataway JC, Heaney D & Porter B (2006) 'Home versus outpatient administration of intravenous steroids for multiple-sclerosis relapses: a randomised controlled trial' The Lancet Neurology 5, (7) 565-571 ,
DOI
Cano SJ, Hobart JC, Edwards M, Fitzpatrick R, Bhatia K, Thompson AJ & Warner TT (2006) 'CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia' Neurology 67, (12) 2230-2232
Riazi A, Cano SJ, Cooper JM, Bradley JL, Schapira AHV & Hobart JC (2006) 'Coordinating outcomes measurement in ataxia research: Do some widely used generic rating scales tick the boxes?' Movement Disorders 21, (9) 1396-1403
Warner M, Baron RA, Ingram WM, Vickery PJ, Reilly S, Wright DE, Zajicek JP & Hobart JC (2006) 'Does the GHQ-30 leave room for change?' Journal of Neurology Neurosurgery and Psychiatry 77, (1)
Cano SJ, O'Connor RJ, Thompson AJ & Hobart JC (2006) 'Exploring disability rating scale responsiveness II: Do more response options help?' Neurology 67, (11) 2056-2059
Hobart JC, Riazi A, Thompson AJ, Styles IM, Ingram W, Vickery PJ, Warner M, Fox PJ & Zajicek JP (2006) 'Getting the measure of spasticity in MS: The Multiple Sclerosis Spasticity Scale (MSSS-88)' Journal of Neurology Neurosurgery and Psychiatry 77, (1)
Hobart JC, Riazi A, Thompson AJ, Styles IM, Ingram W, Vickery PJ, Warner M, Fox PJ & Zajicek JP (2006) 'Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88)' Brain 129, 224-234
Chataway J, Porter B, Riazi A, Heaney D, Watt H, Hobart J & Thompson A (2006) 'Home versus outpatient administration of intravenous steroids for multiple-sclerosis relapses: a randomised controlled trial' Lancet Neurology 5, (7) 565-571
Cano SJ, Hobart JC, Hart PE, Kolipara LVP, Schapira AHV & Cooper JM (2006) 'International co-operative ataxia rating scale (ICARS): Suitable for clinical practice and treatment trials in Friedreich's ataxia?' Journal of Neurology Neurosurgery and Psychiatry 77, (1)
Ingram WM, Hobart JC, Reilly SM, Vickery PJ, Wright DE & Zajicek JP (2006) 'Introducing the south west impact of multiple sclerosis (SWIMS) project: A population-based natural history project to acquire patient-orientated information about the impact of multiple sclerosis' Journal of Neurology Neurosurgery and Psychiatry 77, (1)
Hobart JC, Styles IM, Baron R, Thompson AJ & Andrich D (2006) 'Is it Rasch to compare thee on another scale?' Journal of Neurology Neurosurgery and Psychiatry 77, (1)
Baron R & Hobart J (2006) 'Laughing all the way to the item bank: How to improve your treatment effect by improving your outcome measurement' Journal of Neurology Neurosurgery and Psychiatry 77, (1)
Baron R, Ingram W, Warner M, Vickery PJ, Wright DE, Zajicek J & Hobart JC (2006) 'Meaningless statistics and the illusion of fatigue' Journal of Neurology Neurosurgery and Psychiatry 77, (1)
Baron R, Elashaal A, Germon T & Hobart J (2006) 'Measuring outcomes in cervical spine surgery: Think twice before using the SF-36' Spine 31, (22) 2575-2584
Schrag A, Selai C, Quinn N, Lees A, Litvan I, Lang A, Poon Y, Bower J, Burn D & Hobart J (2006) 'Measuring quality of life in PSP - The PSP-QoL' Neurology 67, (1) 39-44
van der Linden FAH, Kragt JJ, Hobart JC, Klein M, Thompson AJ, van der Ploeg HM, Polman CH & Uitdehaag BMJ (2006) 'Proxy measurements in multiple sclerosis: agreement between patients and their partners on the impact of multiple sclerosis in daily life' Journal of Neurology Neurosurgery and Psychiatry 77, (10) 1157-1162
Hobart JC, Zajicek JP & Thompson AJ (2006) 'Rating scales for neurological diseases: Lessons from Rasch analysis' Journal of Neurology Neurosurgery and Psychiatry 77, (1)
Cano SJ, Riazi A, Cooper JM, Schapira AHV & Hobart JC (2006) 'The Friedreich's Ataxia impact scale (FAIS) meets the needs of today's clinical studies' Journal of Neurology Neurosurgery and Psychiatry 77, (1)
Nicholas R, Vora A, Hobart JC, Malik O & Reynolds R (2006) 'The multiple sclerosis impact scale is sensitive to factors predictive of increasing severity of multiple sclerosis' Multiple Sclerosis 12, S87-S87
Holland A, O'Connor RJ, Thompson AJ, Playford ED & Hobart JC (2006) 'Talking the talk on walking the walk - A 12-item generic walking scale suitable for neurological conditions?' Journal of Neurology 253, (12) 1594-1602
Hobart J (2005) 'How severe is chronic pain in multiple sclerosis?' NATURE CLINICAL PRACTICE NEUROLOGY 1, (2) 80-81 Author Site ,
DOI
Cano SJ, Hobart JC, Hart PE, Korlipara LVP, Schapira AHV & Cooper JM (2005) 'International Cooperative Ataxia Rating Scale (ICARS): appropriate for studies of Friedreich's ataxia?' Mov Disord 20, (12) 1585-1591 Author Site ,
DOI
Nicholl L, Hobart JC, Cramp AFL & Lowe-Strong AS (2005) 'Measuring quality of life in multiple sclerosis: not as simple as it sounds' MULTIPLE SCLEROSIS JOURNAL 11, (6) 708-712 Author Site ,
DOI
Hobart, Riazi A, Styles IM & Thompson AJ (2005) 'Getting the measure of spasticity in Multiple Sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS - 89)' Brain 129, (1) 224-234 ,
DOI
Schrag A, Selai C, Quinn N & Hobart J (2005) 'Measuring health-related quality of life in patients with progressive supranuclear palsy' Neurocase 11, (4) 246-249 Author Site ,
DOI
Freeman JA, Hobart JC, Playford ED, Undy B & Thompson AJ (2005) 'Evaluating neurorehabilitation: lessons from routine data collection' J Neurol Neurosurg Psychiatry 76, (5) 723-728 Author Site ,
DOI
Baron R, Zajicek J, Wright D, Vickery J, Ingram W & Hobart J (2005) 'Confounding the confused: is measuring the frequency and severity of cognitive impairment really necessary?' Multiple Sclerosis 11, S68-S68
Baron R, Zajicek J, Wright D, Vickery J, Ingram W, Reilly S & Hobart J (2005) 'Confounding the confused: Is measuring the frequency and severity of cognitive impairment really necessary?' Journal of the Neurological Sciences 238, S220-S220
Hobart JC, Andrich D, Zajicek JP & Thompson AJ (2005) 'Developing rating scales for multiple sclerosis: lessons from Rasch analysis' Multiple Sclerosis 11, S104-S104
Hobart JC, Zajicek JP & Thompson AJ (2005) 'Developing rating scales for neurological diseases: Lessons from Rasch analysis' Journal of the Neurological Sciences 238, S229-S230
Freeman JA, Hobart JC, Playford ED, Undy B & Thompson AJ (2005) 'Evaluating neurorehabilitation: lessons from routine data collection' Journal of Neurology Neurosurgery and Psychiatry 76, (5) 723-728
Hobart J, Riazi A, Thompson A, Styles I, Ingram W, Vickery J, Warner M, Fox P & Zajicek J (2005) 'Getting the measure of spasticity in MS: the multiple sclerosis spasticity scale' Multiple Sclerosis 11, S104-S104
Hobart JC, Riazi A, Thompson AJ, Styles IM, Ingram W, Vickery PJ, Warner M, Fox PJ & Zajicek JP (2005) 'Getting the measure of spasticity in MS: The Multiple Sclerosis Spasticity Scale (MSSS-88)' Journal of the Neurological Sciences 238, S229-S229
Chataway J, Porter B, Hobart J, Heaney D, Riazi A & Thompson AJ (2005) 'Home or away? A randomised controlled trial of treating acute multiple sclerosis relapses with intravenous steroids' Multiple Sclerosis 11, S181-S181
Hobart JC, Riazi A, Lamping DL, Fitzpatrick R & Thompson AJ (2005) 'How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self report scales' Journal of Neurology Neurosurgery and Psychiatry 76, (11) 1539-1543
Hobart JC, Riazi A, Lamping DL, Fitzpatrick R & Thompson AJ (2005) 'How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self report scales' Journal of Neurology, Neurosurgery and Psychiatry 76, (11) 1539-1543 ,
DOI
Hobart J (2005) 'How severe is chronic pain in multiple sclerosis?' Nature Clinical Practice Neurology 1, (2) 80-81
Cano SJ, Hobart JC, Hart PE, Korlipara LVP, Schapira AH & Cooper JM (2005) 'International Cooperative Ataxia Rating Scale (ICARS): Appropriate for studies of Friedreich's ataxia?' Movement Disorders 20, (12) 1585-1591
Ingram W, Hobart J, Reilly S, Vickery P, Wright D & Zajicek J (2005) 'Introducing the South West Impact of Multiple Sclerosis Project: a patient-focused natural history study of multiple sclerosis' Multiple Sclerosis 11, S110-S110
Hobart J, Styles L, Baron R, Thompson A & Andrich D (2005) 'Is it Rasch to compare thee on another scale?' Multiple Sclerosis 11, S104-S104
Hobart JC, Styles IM, Baron R, Thompson AJ & Andrich D (2005) 'Is it Rasch to compare thee on another scale?' Journal of the Neurological Sciences 238, S221-S221
Baron R & Hobart J (2005) 'Laughing all the way to the item bank: how to improve your treatment effect by improving your outcome measurement' Journal of the Neurological Sciences 238, S220-S221
Baron R, Ingram W, Warner M, Vickery J, Wright D, Zajicek J & Hobart J (2005) 'Meaningless statistics and the illusion of fatigue measurement' Multiple Sclerosis 11, S68-S68
Schrag A, Selai C, Quinn N & Hobart J (2005) 'Measuring health-related quality of life in patients with progressive supranuclear palsy' Neurocase 11, (4) 246-249
Nicholl L, Hobart JC, Cramp AFL & Lowe-Strong AS (2005) 'Measuring quality of life in multiple sclerosis: not as simple as it sounds' Multiple Sclerosis 11, (6) 708-712
Carroll CB, Bain PG, Teare L, Liu X, Joint C, Wroath C, Parkin SG, Fox P, Wright D & Hobart J (2004) 'Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study' Neurology 63, (7) 1245-1250 Author Site ,
DOI
Cano SJ, Hobart JC, Fitzpatrick R, Bhatia K, Thompson AJ & Warner TT (2004) 'Patient-based outcomes of cervical dystonia: a review of rating scales' Mov Disord 19, (9) 1054-1059 Author Site ,
DOI
O'Connor RJ, Cano SJ, Thompson AJ & Hobart JC (2004) 'Exploring rating scale responsiveness: does the total score reflect the sum of its parts?' Neurology 62, (10) 1842-1844 Author Site ,
DOI
Carroll C, Hobart J, Fox C, Teare L & Gibson J (2004) 'Stroke in Devon: knowledge was good, but action was poor' J Neurol Neurosurg Psychiatry 75, (4) 567-571 Author Site ,
DOI Open access
Hobart JC, Riazi A, Lamping DL, Fitzpatrick R & Thompson AJ (2004) 'Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome' Health Technol Assess 8, (9) iii-48 Author Site ,
DOI
Hobart J, Kalkers N, Barkhof F, Uitdehaag B, Polman C & Thompson A (2004) 'Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite' Mult Scler 10, (1) 41-46 Author Site ,
DOI
Riazi A, Thompson AJ & Hobart JC (2004) 'Self-efficacy predicts self-reported health status in multiple sclerosis' Mult Scler 10, (1) 61-66 Author Site ,
DOI
Carroll CB, Bain PG, Teare L, Liu X, Joint C, Wroath C, Parkin SG, Fox P, Wright D & Hobart J (2004) 'Cannabis for dyskinesia in Parkinson disease - A randomized double-blind crossover study' Neurology 63, (7) 1245-1250
Cano SJ, Warner TT, Linacre JM, Bhatia KP, Thompson AJ, Fitzpatrick R & Hobart JC (2004) 'Capturing the true burden of dystonia on patients - The Cervical Dystonia Impact Profile (CDIP-58)' Neurology 63, (9) 1629-1633
Zajicek J, Thompson A & Hobart J (2004) 'Clinical trials in multiple sclerosis - The importance of the outcome measure' Journal of Neurology Neurosurgery and Psychiatry 75, (8)
Hobart J, Cano S, O'Connor R, Kinos S, Heinzlef O, Roullet E, Polman C, Uitdehaag B, McGuigan C & Hutchinson M (2004) 'Clinical trials in neurology: Are rating scales stable across European countries?' Journal of Neurology Neurosurgery and Psychiatry 75, (5)
O'Connor RJ, Cano SJ, Thompson AJ & Hobart JC (2004) 'Exploring rating scale responsiveness - Does the total score reflect the sum of its parts?' Neurology 62, (10) 1842-1844
Hobart JC, Riazi A, Lamping DL, Fitzpatrick R & Thompson AJ (2004) 'Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome' Health Technology Assessment 8, (9) 1-+
Nicholl L, Hobart J, Dunwoody L, Cramp F & Lowe-Strong A (2004) 'Measuring disability in multiple sclerosis: is the Community Dependency Index an improvement on the Barthel Index?' MULTIPLE SCLEROSIS JOURNAL 10, (4) 447-450 Author Site ,
DOI
Nicholl L, Hobart J, Dunwoody L, Cramp F & Lowe-Strong A (2004) 'Measuring disability in multiple sclerosis: is the Community Dependency Index an improvement on the Barthel Index?' Multiple Sclerosis 10, (4) 447-450
Hobart J, Kalkers N, Barkhof F, Uitdehaag B, Polman C & Thompson A (2004) 'Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite' Multiple Sclerosis 10, (1) 41-46
Cano SJ, Hobart JC, Fitzpatrick R, Bhatia K, Thompson AJ & Warner TT (2004) 'Patient-based outcomes of cervical dystonia: A review of rating scales' Movement Disorders 19, (9) 1054-1059
Riazi A, Thompson AJ & Hobart JC (2004) 'Self-efficacy predicts self-reported health status in multiple sclerosis' Multiple Sclerosis 10, (1) 61-66
Carroll C, Hobart J, Fox C, Teare L & Gibson J (2004) 'Stroke in Devon: knowledge was good, but action was poor' Journal of Neurology Neurosurgery and Psychiatry 75, (4) 567-571
Cano SJ, Warner TT, Fitzpatrick R, Bhatia K, Thompson AJ & Hobart JC (2004) 'The cervical dystonia impact profile (CDIP-58): A new patient-based rating scale' Journal of Neurology Neurosurgery and Psychiatry 75, (8)
Nicholl L, Hobart J, Cramp F & Lowe-Strong AS (2004) 'The Leeds Multiple Sclerosis Quality of Life Scale: a further psychometric evaluation' Multiple Sclerosis 10, (7032) S99-S100
Zajicek J, Thompson A & Hobart J (2004) 'Cutting the cost and length of clinical trials - the importance of choosing the right outcome measure' Journal of Neurology 251, 152-153
Hobart J (2003) 'Rating scales for neurologists' J Neurol Neurosurg Psychiatry 74 Suppl 4, (Suppl 4) iv22-iv26 Author Site ,
DOI
Hobart J (2003) 'Rating scales for neurologists' JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY 74, 22-26 Author Site
Riazi A, Hobart JC, Fitzpatrick R, Freeman JA & Thompson AJ (2003) 'Socio-demographic variables are limited predictors of health status in multiple sclerosis' J Neurol 250, (9) 1088-1093 Author Site ,
DOI
Mundy HR, Jones SJ, Hobart JC, Hanna MG & Lee PJ (2003) 'A randomized controlled study of modified cobratoxin in adrenomyeloneuropathy' Neurology 61, (4) 528-530 Author Site ,
DOI
Riazi A, Hobart JC, Lamping DL, Fitzpatrick R & Thompson AJ (2003) 'Evidence-based measurement in multiple sclerosis: the psychometric properties of the physical and psychological dimensions of three quality of life rating scales' Mult Scler 9, (4) 411-419 Author Site ,
DOI
Riazi A, Hobart JC, Lamping DL, Fitzpatrick R, Freeman JA, Jenkinson C, Peto V & Thompson AJ (2003) 'Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles' J Neurol Neurosurg Psychiatry 74, (6) 710-714 Author Site ,
DOI
Hobart JC, Riazi A, Lamping DL, Fitzpatrick R & Thompson AJ (2003) 'Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12)' Neurology 60, (1) 31-36 Author Site ,
DOI
Edwards SGM, Playford ED, Hobart JC & Thompson AJ (2003) 'Comparison of physician outcome measures and patients' perception of benefits of inpatient neurorehabilitation' Journal of Neurology Neurosurgery and Psychiatry 74, (8)
Riazi A, Hobart JC, Lamping DL, Fitzpatrick R & Thompson AJ (2003) 'Evidence-based measurement in multiple sclerosis: the psychometric properties of the physical and psychological dimensions of three quality of life rating scales' Multiple Sclerosis 9, (4) 411-419
Hobart JC, Riazi A, Lamping DL, Fitzpatrick R & Thompson AJ (2003) 'Measuring the impact of MS on walking ability - The 12-Item MS Walking Scale (MSWS-12)' Neurology 60, (1) 31-36
Hobart J (2003) 'Rating scales for neurologists' Journal of Neurology Neurosurgery and Psychiatry 74, 22-26
Carroll C, Hobart J, Fox C, Teare L & Gibson J (2003) 'Stroke in Devon: The need to translate knowledge into action' Journal of Neurology Neurosurgery and Psychiatry 74, (8)
Riazi A, Hobart JC, Lamping DL, Fitzpatrick R, Freeman JA, Jenkinson C, Peto V & Thompson AJ (2003) 'Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles' Journal of Neurology Neurosurgery and Psychiatry 74, (6) 710-714
Riazi A, Hobart JC, Fitzpatrick R, Freeman JA & Thompson AJ (2003) 'Socio-demographic variables are limited predictors of health status in multiple sclerosis' Journal of Neurology 250, (9) 1088-1093
Hobart J (2002) 'Measuring disease impact in disabling neurological conditions: are patients' perspectives and scientific rigor compatible?' Curr Opin Neurol 15, (6) 721-724 Author Site ,
DOI
Riazi A, Hobart JC, Lamping DL, Fitzpatrick R & Thompson AJ (2002) 'Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples' J Neurol Neurosurg Psychiatry 73, (6) 701-704 Author Site ,
DOI
Hobart J, Riazi A, Lamping D, Fitzpatrick R & Thompson AJ (2002) 'Evaluating the use of B-INTERFERON in the UK: From whose perspective?' JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY 73, (2) 227-227 Author Site
Edwards SGM, Playford ED, Hobart JC & Thompson AJ (2002) 'Comparison of physician outcome measures and patients' perception of benefits of inpatient neurorehabilitation' BMJ 324, (7352) Author Site ,
DOI
Hobart JC, Williams LS, Moran K & Thompson AJ (2002) 'Quality of life measurement after stroke: uses and abuses of the SF-36' Stroke 33, (5) 1348-1356 Author Site ,
DOI
Jenkinson C, Hobart J, Chandola T, Fitzpatrick R, Peto V, Swash M & ALS-HPS Steering Group. Amyotrophic Lateral Sclerosis Health Profile Study (2002) 'Use of the short form health survey (SF-36) in patients with amyotrophic lateral sclerosis: tests of data quality, score reliability, response rate and scaling assumptions' J Neurol 249, (2) 178-183 Author Site ,
DOI
Hobart J, Riazi A, Lamping D, Fitzpatrick R & Thompson AJ (2002) 'Evaluating the use of B-INTERFERON in the UK: From whose perspective?' Journal of Neurology Neurosurgery and Psychiatry 73, (2) 227-227
Hobart J (2002) 'Measuring disease impact in disabling neurological conditions: are patients' perspectives and scientific rigor compatible?' Current Opinion in Neurology 15, (6) 721-724
Riazi A, Hobart JC, Lamping DL, Fitzpatrick R & Thompson AJ (2002) 'Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples' Journal of Neurology Neurosurgery and Psychiatry 73, (6) 701-704
Hobart JC, Williams LS, Moran K & Thompson AJ (2002) 'Quality of life measurement after stroke - Uses and abuses of the SF-36' Stroke 33, (5) 1348-1356
Edwards SGM, Playford ED, Hobart JC & Thompson AJ (2002) 'Comparison of physician outcome measures and patients' perception of benefits of inpatient neurorehabilitation' British Medical Journal 324, (7352) 1493-1493
Hobart JC, Lamping DL, Freeman JA, Greenwood RJ, McLellan DL & Thompson A (2001) 'Evidence-based measurement: which disability scale for neurological rehabilitation?' Neurology 57, 639-644
Hobart JC, Freeman JA, Fitzpatrick R & Thompson A (2001) 'The SF-36 in multiple sclerosis: why basic assumptions must be tested' Journal of Neurology, Neurosurgery and Psychiatry 71, (3) 363-370
Hobart J, Freeman J, Lamping D, Fitzpatrick R & Thompson A (2001) 'The SF-36 in multiple sclerosis: why basic assumptions must be tested' J Neurol Neurosurg Psychiatry 71, (3) 363-370 Author Site ,
DOI
Hobart JC & Thompson AJ (2001) 'The five item Barthel index' J Neurol Neurosurg Psychiatry 71, (2) 225-230 Author Site ,
DOI
Freeman JA, Hobart JC & Thompson AJ (2001) 'Does adding MS-specific items to a generic measure (the SF-36) improve measurement?' Neurology 57, (1) 68-74 Author Site ,
DOI
Manson AJ, Katzenschlager R, Hobart J & Lees AJ (2001) 'High dose naltrexone for dyskinesias induced by levodopa' J Neurol Neurosurg Psychiatry 70, (4) 554-556 Author Site ,
DOI
Hobart, Freeman JA, Lamping DL & Langdon DW (2001) 'Evidence-based measurement: which disability scale for neurologic rehabilitation?' Neurology 57, 639-644
Hobart, Fitzpatrick R, Lamping D & Riazi A (2001) 'The multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure' Brain 124, (5) 962-973 ,
DOI
Hobart (2001) 'The multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure' Brain 124 (5), 962-973 ,
DOI
Hobart J, Freeman J & Thompson A (2000) 'Kurtzke scales revisited: the application of psychometric methods to clinical intuition' Brain 123 ( Pt 5), 1027-1040 Author Site ,
DOI
Freeman JA, Hobart JC, Langdon DW & Thompson AJ (2000) 'Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis' J Neurol Neurosurg Psychiatry 68, (2) 150-156 Author Site ,
DOI
van der Putten JJ, Hobart JC, Freeman JA & Thompson AJ (1999) 'Measuring change in disability after inpatient rehabilitation: comparison of the responsiveness of the Barthel index and the Functional Independence Measure' J Neurol Neurosurg Psychiatry 66, (4) 480-484 Author Site ,
DOI
Freeman JA, Langdon DW, Hobart JC & Thompson AJ (1999) 'Inpatient rehabilitation in multiple sclerosis: do the benefits carry over into the community?' Neurology 52, (1) 50-56 Author Site ,
DOI
Freeman JA, Langdon DW, Hobart JC & Thompson AJ (1998) '*The Impact of In-patient Rehabilitation on Disability and Handicap in Progressive Multiple Sclerosis: A randomised controlled trial' Physiotherapy 84, (8) 401-401 ,
DOI
Thompson AJ & Hobart JC (1998) 'Multiple sclerosis: assessment of disability and disability scales' J Neurol 245, (4) 189-196 Author Site ,
DOI
Freeman JA, Langdon DW, Hobart JC & Thompson AJ (1997) 'The impact of inpatient rehabilitation on progressive multiple sclerosis' Ann Neurol 42, (2) 236-244 Author Site ,
DOI
Hobart J & Thompson A (1997) 'A comparison of two neurologic scoring instruments for multiple sclerosis' JOURNAL OF NEUROLOGY 244, (1) 60-60 Author Site
Hobart JC, Freeman JA & Lamping DL (1996) 'Physician and patient-oriented outcomes in progressive neurological disease: which to measure?' Curr Opin Neurol 9, (6) 441-444 Author Site ,
DOI
Hobart JC, Lamping DL & Thompson AJ (1996) 'Evaluating neurological outcome measures: The bare essentials' JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY 60, (2) 127-130 Author Site ,
DOI
Freeman JA, Hobart JC & Thompson AJ (1996) 'Outcomes-based research in neurorehabilitation: the need for multidisciplinary team involvement' Disabil Rehabil 18, (2) 106-110 Author Site ,
DOI
Hobart JC, Freeman JA & Lamping DL (1996) 'Evaluating outcome measurement instruments' MS Management 1, (2) 6-12
Freeman JA, Langdon DW, Hobart JC & Thompson AJ (1996) 'Health-related quality of life in people with multiple sclerosis undergoing inpatient rehabilitation' JOURNAL OF NEUROLOGIC REHABILITATION 10, (3) 185-194 Author Site
Freeman JA, Langdon DW, Hobart JC & Thompson AJ (1995) 'Reduced Disability Following Rehabilitation in Patients with Progressive Multiple Sclerosis' Physiotherapy 81, (8) 457-457 ,
DOI
Freeman JA, Hobart JC, Langdon DW & Thompson AJ (1995) 'Immediate and long term effects of inpatient rehabilitation in progressive multiple sclerosis (MS): Initial report' Journal of Neuroimmunology 56-63, 52-52 ,
DOI
Dash P, Hobart J, Malik K, Janmohamed S & Hill-Smith A (1990) 'A view from the other side' Health Services Journal 100(5230),